
Regentis Biomaterials Ltd. (RGNT) Stock Ticker
Market factors today
Unlock the full RGNT picture
About Regentis Biomaterials Ltd.
Regentis Biomaterials Ltd. is a regenerative medicine firm dedicated to crafting innovative solutions for tissue repair, ultimately aiming to enhance patients' health and overall quality of life. The company's primary product in development is GelrinC, a novel, cell-free, ready-to-use hydrogel designed to be solidified into an implant within the knee. This implant serves to address painful knee injuries and mend articular cartilage damage. Regentis Biomaterials leverages its proprietary Gelrin platform, which employs biodegradable hydrogel implants, to develop orthopedic therapies that facilitate the regeneration of compromised or diseased tissues. The company was established in 2004 and operates from its headquarters in Herzliya, Israel.
RGNT stock facts
| Ticker symbol | RGNT |
| Exchange | New York Stock Exchange Arca |
| Sector | Healthcare |
| Industry | Medical - Instruments & Supplies |
| Market cap | $13.3M |
| CEO | Ehud Geller |
| Employees | 10 |
| Headquarters | Herzliya, TA, IL |
| IPO date | 2025-12-04 |
| Website | www.regentis.co.il |
What you can see for RGNT on Tickr
Live RGNT price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the RGNT report.
Rankings
FAQ
What is the ticker symbol for Regentis Biomaterials Ltd.?
The ticker symbol for Regentis Biomaterials Ltd. is RGNT, listed on the New York Stock Exchange Arca.
What is RGNT?
Regentis Biomaterials Ltd. is a regenerative medicine firm dedicated to crafting innovative solutions for tissue repair, ultimately aiming to enhance patients' health and overall quality of life. The company's primary product in development is GelrinC, a novel, cell-free, ready-to-use hydrogel designed to be solidified into an implant within the knee. This implant serves to address painful knee…